Efficacy of treatment for ulcerative colitis.
作者信息
Steinberg H
出版信息
JAMA. 1998 Aug 5;280(5):422. doi: 10.1001/jama.280.5.422-a.
PMID:9701075
Abstract
摘要
相似文献
1
Efficacy of treatment for ulcerative colitis.
JAMA. 1998 Aug 5;280(5):422. doi: 10.1001/jama.280.5.422-a.
2
Rolling review: inflammatory bowel disease.
Aliment Pharmacol Ther. 1993 Oct;7(5):567-79. doi: 10.1111/j.1365-2036.1993.tb00134.x.
3
Ulcerative colitis: responding to the challenges.溃疡性结肠炎：应对挑战
Cleve Clin J Med. 2007 Sep;74(9):657-60. doi: 10.3949/ccjm.74.9.657.
4
Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.柳氮磺胺吡啶的不良反应及美沙拉嗪治疗溃疡性结肠炎
J Gastroenterol. 1995 Nov;30 Suppl 8:115-7.
5
Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.一名溃疡性结肠炎患者出现柳氮磺胺吡啶诱导的心包炎，改用美沙拉嗪后未复发。
Int J Colorectal Dis. 2007 Sep;22(9):1119-21. doi: 10.1007/s00384-007-0310-2. Epub 2007 Apr 18.
6
Oral mesalamine for ulcerative colitis.
Med Lett Drugs Ther. 1992 Aug 21;34(877):80-1.
7
Active moiety of sulfasalazine.
Dig Dis Sci. 1989 Nov;34(11):1804-5. doi: 10.1007/BF01540065.
8
[Pharmacological bases of therapy with 5-ASA].[5-氨基水杨酸治疗的药理学基础]
Gastroenterol Hepatol. 1997 Jun-Jul;20(6):322-34.
9
10
Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.口服美沙拉嗪治疗溃疡性结肠炎：药物剂型、疗效预期、剂量反应、依从性及化学预防的进展
Rev Gastroenterol Disord. 2006 Spring;6(2):97-105.
Zotero 插件